EUCAIM

European Federation for Cancer Images
Category: European
Funding Agency: European Commission
Programme: DIGITAL-SIMPLE
Programme Nature: DIGITAL-2022-CLOUD-AI-02-CANCER-IMAGE
Coordinator: Luis Marti Bonmati
Start Date: 01.01.2023
Expiration Date: 31.12.2026
Duration: 48 months
Total Budget: 26424656,00€
FORTH ICS Budget: 451497,20€
Related URL: https://cancerimage.eu/
Partners: EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG (EIBIR), FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA (HULAFE), UNIVERSITAT POLITECNICA DE VALENCIA (UPV), IDRYMA TECHNOLOGIAS KAI EREVNAS (FORTH), DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (DKFZ), ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (ERASMUS MC), MAGGIOLI SPA (MAG), UNIVERSITAT DE BARCELONA (UB), UMEA UNIVERSITET (UMU), EATRIS ERIC (EATRIS), MATICAL INNOVATION SL (MAT), EURO-BIOIMAGING ERIC (EURO-BIOIMAGING), ARISTOTELIO PANEPISTIMIO THESSALONIKIS (AUTH), ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (APHP), BAHIA SOFTWARE SL (BAHIA), FUNDACIO CENTRE DE REGULACIO GENOMICA (CRG-CERCA), FUNDACAO D. ANNA DE SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD (CF),  CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (CNRS), COLLEGE DES ENSEIGNANTS DE RADIOLOGIE DE FRANCE (CERF), MEDIZINISCHE UNIVERSITAET WIEN (MUW), AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC), FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS (FPG), LINAC-PET SCAN OPCO LIMITED (GOC), POLICLINICO SAN DONATO SPA (PSD), STICHTING HEALTH-RI (Health-RI), FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA (FCRB), ELLINIKI ANTIKARNIKI ETAIREIA (HCS), SERVICIO MADRILENO DE SALUD (SERMAS), SERVICIO ANDALUZ DE SALUD (SAS), IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS (IFOM), INSTITUTO TECNOLOGICO DE INFORMATICA (ITI), SYNLAB SDN SPA (SYNLAB), KAROLINSKA INSTITUTET (KI), SORBONNE UNIVERSITE (LIMICS), LINKOPINGS UNIVERSITET (LIU), MEDEXPRIM (MEDEX), UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA (Sapienza), CONSIGLIO NAZIONALE DELLE RICERCHE (CNR), STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI), PHILIPS GMBH (Philips), QUIBIM SOCIEDAD LIMITADA (QUIBIM), STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM (RADBOUDUMC), SCIENSANO (Sciensano), KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN (TUM-MED), UNIVERSITA DI PISA (UNIPI), UNIVERSITEIT MAASTRICHT (UM), UNIVERSITAETSKLINIKUM AACHEN (UKA), UPPSALA UNIVERSITET (UU), UNIVERSITAT DE VALENCIA (UV), OWKIN FRANCE (OWKIN), ONCORADIOMICS (RAD), SPMS - SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE (SPMS), STICHTING EGI (EGI), GDANSKI UNIWERSYTET MEDYCZNY (GUMed), BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION (BSC), INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE (INRIA), S2 GRUPO DE INNOVACION EN PROCESOS ORGANIZATIVOS SL (S2G), CENTRO HOSPITALAR UNIVERSITARIO DO PORTO EPE (CHUP), BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC) (BBMRI), COMITE EUROPEEN DE COORDINATION DES INDUSTRIES RADIOLOGIQUES ELECTROMEDICALES ET D INFORMATIQUE DE SANTE AISBL (COCIR), CHARITE - UNIVERSITAETSMEDIZIN BERLIN (Charité), REGION VASTERBOTTEN (RegVB), IQVIA INFORMATION SA (IQVIA), INSTITUTO DE SALUD CARLOS III (ISCIII), EUROPEAN MOLECULAR BIOLOGY LABORATORY (ELIXIR),
Description:
Cancer Image Europe is pioneering a pan-European federated infrastructure for cancer images, fueling AI innovations. Cancer Image Europe provides a robust, trustworthy platform for researchers, clinicians, and innovators to access diverse cancer images, enabling the benchmarking, testing, and piloting of AI-driven technologies. By connecting high-quality cancer image data and AI experts, Cancer Image Europe facilitates collaboration and accelerates the development of cutting-edge solutions for cancer diagnosis and treatment.
Objectives:

EUropean Federation for CAncer IMages (EUCAIM) is the cornerstone of the European Commission-initiated European Cancer Imaging Initiative, a flagship of Europe’s Beating Cancer Plan (EBCP), which aims to foster innovation and deployment of digital technologies in cancer treatment and care to achieve more precise and faster clinical decision making, diagnostics, treatment and predictive medicine for cancer patients.

Health data, including medical images, are highly distributed and fragmented in Europe. Artificial Intelligence (AI) offers a paradigm shift towards data-driven decision making that is revolutionising medicine. In medical imaging, an increasing number of studies are appearing in which AI tools are making important contributions towards a more accurate diagnosis or a more reliable treatment response and prognostic prediction. However, there can be a significant difference between the design and the real-world performance of algorithms, leading to ethical and safety issues. The aim of EUCAIM is to address this issue: to deploy a federated, pan-European research infrastructure in order to address the fragmentation of the health data and medical images in Europe. This research infrastructure will support the development and validation of AI tools toward Precision Medicine. Such AI tools will support and enhance the (cancer) diagnosis procedure, treatment and the identification of the need for predictive medicine. Overall, this infrastructure will provide a platform for developing AI tools that aim to enhance cancer treatment and the diagnosis procedure for patients. EUCAIM will build on the already existing, but fragmented data repositories of cancer images developed through the projects of the AI4HI initiative. Furthermore, we will also define the legal grounds for the operation of the federated data repository on the European scale by adapting to the particularities of the data management regulations of the different European countries. Preserving the data sovereignty of the data providers has a high priority in EUCAIM. The EUCAIM consortium consist of 76 partners from 14 countries. Many of the partners are part of the AI4HI initiative or major European Research Infrastructures (such as Euro-BioImaging, BBMRI, EATRIS and ELIXIR). 

Contact person(s) from ICS:
 Tsiknakis Manolis N.